Literature DB >> 11168747

The cutaneous pathology of lupus erythematosus: a review.

A N Crowson1, C Magro.   

Abstract

The presentation of lupus erythematosus (LE) ranges from a skin rash unaccompanied by extracutaneous stigmata to a rapidly progressive lethal multiorgan disease. The diagnosis and subclassification is traditionally based on the correlation of serological and clinical findings. The latter include a photoinduced skin rash, arthralgia, arthritis, fever, Raynaud's phenomenon, anemia, leukopenia, serositis, nephritis and central nervous sysdtem disease. The conventional classification scheme includes systemic, subacute cutaneous and discoid LE. Recent advances in our understanding of the cutaneous histopathology which correlates with the traditional forms of LE, along with certain novel LE subtypes, are the focus of this review. In addition to the main subtypes of LE, we will discuss associated vasculopathic lesions and the contribution of immunofluorescence microscopy to the diagnosis of LE and related connective tissue disease syndromes. Consideration will be given to unusual variants of LE such as anti-Ro/SSA-positive systemic lupus erythematosus (SLE), bullous SLE, lymphomatoid LE, lupus erythematosus profundus, drug induced LE, linear cutaneous LE, chiblains LE and parvovirus B19-associated LE.

Entities:  

Mesh:

Year:  2001        PMID: 11168747     DOI: 10.1034/j.1600-0560.2001.280101.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  28 in total

Review 1.  [Vasculitides: classification, clinical aspects and pathology. A review].

Authors:  Peter Meister
Journal:  Pathologe       Date:  2003-04-08       Impact factor: 1.011

Review 2.  My approach to superficial inflammatory dermatoses.

Authors:  K O Alsaad; D Ghazarian
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

3.  [Cutaneous lupus erythematosus. Part 1: clinical manifestations and classification].

Authors:  A Kuhn; K Gensch; S Ständer; G Bonsmann
Journal:  Hautarzt       Date:  2006-03       Impact factor: 0.751

4.  Chilblain lupus erythematosus.

Authors:  Sapna Patel; Faddy Hardo
Journal:  BMJ Case Rep       Date:  2013-11-27

5.  Fas ligand promotes an inducible TLR-dependent model of cutaneous lupus-like inflammation.

Authors:  Purvi Mande; Bahar Zirak; Wei-Che Ko; Keyon Taravati; Karen L Bride; Tia Y Brodeur; April Deng; Karen Dresser; Zhaozhao Jiang; Rachel Ettinger; Katherine A Fitzgerald; Michael D Rosenblum; John E Harris; Ann Marshak-Rothstein
Journal:  J Clin Invest       Date:  2018-06-11       Impact factor: 14.808

6.  Lupus serum IgG induces skin inflammation through the TNFR1 signaling pathway.

Authors:  Guo-Min Deng; Lena Liu; Vasileios C Kyttaris; George C Tsokos
Journal:  J Immunol       Date:  2010-05-14       Impact factor: 5.422

Review 7.  The Cutaneous Spectrum of Lupus Erythematosus.

Authors:  Simone Ribero; Savino Sciascia; Luca Borradori; Dan Lipsker
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

Review 8.  Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation.

Authors:  Thrasivoulos George Tzellos; Dimitrios Kouvelas
Journal:  Eur J Clin Pharmacol       Date:  2007-12-20       Impact factor: 2.953

Review 9.  Cutaneous lupus erythematosus: diagnosis and treatment.

Authors:  L G Okon; V P Werth
Journal:  Best Pract Res Clin Rheumatol       Date:  2013-06       Impact factor: 4.098

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.